EP. 1: Dr. O’Shaughnessy on Adjuvant Abemaciclib in High-Risk Early Breast Cancer
March 1st 2023
Joyce O’Shaughnessy, MD, discusses the findings from the phase 3 monarchE trial of adjuvant endocrine therapy with or without abemaciclib in patients with hormone receptor–positive, HER2-negative, node-positive, high-risk early breast cancer.